Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT07331467
What this trial is testing

Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus
Chongqing Precision Biotech Co., Ltd 18
Very early researchLooking for participantsNCT06446128
What this trial is testing

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Who this might be right for
Non-Hodgkin Lymphoma, B-cell
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Not Yet RecruitingNCT07341828
What this trial is testing

C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorders (NMOSD)Autoimmune Encephalitis+1 more
Huashan Hospital 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117305
What this trial is testing

CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
CD7+ LymphomaT Cell Lymphoma
Zhengzhou University 38
Testing effectiveness (Phase 2)UnknownNCT04163302
What this trial is testing

Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Chinese PLA General Hospital 30
Not applicableLooking for participantsNCT07509450
What this trial is testing

Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study

Who this might be right for
Lymphoma Receiving CAR-T Therapy
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Looking for participantsNCT07480213
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCSCLC, Extensive Stage
Beijing Biotech 60
Not applicableNot Yet RecruitingNCT07683897
What this trial is testing

A Long-Term Follow-Up Trial for Participants Enrolled in CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) Trials

Who this might be right for
Participants Treated With Senza5
Vittoria Biotherapeutics 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510100
What this trial is testing

Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 17
Very early researchUnknownNCT04923919
What this trial is testing

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 100
Very early researchNot Yet RecruitingNCT07395050
What this trial is testing

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

Who this might be right for
Stage 3 Type 1 Diabetes
City of Hope Medical Center 6
Not applicableUnknownNCT05752877
What this trial is testing

Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma

Who this might be right for
Advanced GliomaComplication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
Second Affiliated Hospital of Soochow University 12
Very early researchUnknownNCT05013372
What this trial is testing

CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Who this might be right for
T-cell Non-Hodgkin's Lymphoma
Peking University People's Hospital 12
Early research (Phase 1)UnknownNCT02933775
What this trial is testing

CD19-redirected Autologous Cells (CAR-CD19 T Cells)

Who this might be right for
CD19 Positive Malignant B-cell Leukemia and Lymphoma
RenJi Hospital 45
Early research (Phase 1)Looking for participantsNCT07211737
What this trial is testing

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+1 more
Baylor College of Medicine 27
Early research (Phase 1)Ended earlyNCT04230265
What this trial is testing

Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)
AvenCell Europe GmbH 32
Early research (Phase 1)Looking for participantsNCT06934447
What this trial is testing

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

Who this might be right for
CAR T Cell TherapySystemic Lupus ErythematosusBCMA
The Children's Hospital of Zhejiang University School of Medicine 18
Early research (Phase 1)Looking for participantsNCT06815432
What this trial is testing

GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Baylor College of Medicine 27
Testing effectiveness (Phase 2)Looking for participantsNCT05480449
What this trial is testing

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Who this might be right for
B Cell Acute Lymphoblastic Leukemia (B-ALL)B Lineage Lymphoblastic Lymphoma
Stephan Grupp MD PhD 115
Next Page